Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Feb;62(2):140–145. doi: 10.1136/ard.62.2.140

Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis

A van Tubergen 1, R Landewe 1, L Heuft-Dorenbosch 1, A Spoorenberg 1, D van der Heijde 1, H van der Tempel 1, S van der Linden 1
PMCID: PMC1754428  PMID: 12525383

Abstract

Objective: To investigate in ankylosing spondylitis (AS) whether the newly developed World Health Organisation Disability Assessment Schedule II (WHODAS II) is a useful instrument for measuring disability, to assess its responsiveness in relation to other traditional disease specific instruments, and to identify factors that are associated with both short term and long term scores on the WHODAS II.

Methods: Patients with AS from a randomised controlled trial assessing the efficacy of spa treatment (n=117) and from a five year longitudinal observational study (n=97) participated. The patients completed several questionnaires, including the WHODAS II. After a three week course of spa treatment, 31 patients again completed all questionnaires to assess responsiveness. To determine to what degree the WHODAS II reflects some AS oriented measures on disease activity, functioning, and quality of life, correlation coefficients between the WHODAS II and these other questionnaires were calculated. Responsiveness was calculated by the effect size (ES) and standardised response mean (SRM). Linear regression analysis was performed to explore which factors might be associated with short term changes on the WHODAS II and to investigate (in the observational study) which factors of WHODAS II might predict disability five years later.

Results: Mean score on the WHODAS II was 23.9 (SD 15.5 (range 0.0-76.1)). Scores on the WHODAS II were significantly correlated with all disease specific questionnaires measured (all p<0.001). The WHODAS II showed a comparable short term responsiveness score (SRM 0.41; ES 0.39). In regression analysis these short term changes on the WHODAS II were significantly associated with changes in functioning (ß coefficient 4.25, 95% confidence interval (95% CI) 1.24 to 7.26, p=0.007). In the observational study, disease activity (ß coefficient 0.35, 95% CI 0.17 to 0.53, p<0.000) as well as functioning (ß coefficient 0.23, 95% CI 0.09 to 0.38, p=0.002) seemed to significantly predict disability (WHODAS II) after five years.

Conclusion: The WHODAS II is a useful instrument for measuring disability in AS in that it accurately reflects disease specific instruments and that it shows similar responsiveness scores. In AS, a short term change on the WHODAS II is associated with a change in physical function. At the group level, disease activity and physical functioning may predict disability after five years.

Full Text

The Full Text of this article is available as a PDF (113.9 KB).

Figure 1.

Figure 1

Open in a new tab

WHODAS II plotted against the BASFI and the ASQoL.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott C. A., Helliwell P. S., Chamberlain M. A. Functional assessment in ankylosing spondylitis: evaluation of a new self-administered questionnaire and correlation with anthropometric variables. Br J Rheumatol. 1994 Nov;33(11):1060–1066. doi: 10.1093/rheumatology/33.11.1060. [DOI] [PubMed] [Google Scholar]
  2. Calin A., Garrett S., Whitelock H., Kennedy L. G., O'Hea J., Mallorie P., Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994 Dec;21(12):2281–2285. [PubMed] [Google Scholar]
  3. Calin A., Mackay K., Santos H., Brophy S. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol. 1999 Apr;26(4):988–992. [PubMed] [Google Scholar]
  4. Calin A., Nakache J. P., Gueguen A., Zeidler H., Mielants H., Dougados M. Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity. J Rheumatol. 1999 Apr;26(4):975–979. [PubMed] [Google Scholar]
  5. Carette S., Graham D., Little H., Rubenstein J., Rosen P. The natural disease course of ankylosing spondylitis. Arthritis Rheum. 1983 Feb;26(2):186–190. doi: 10.1002/art.1780260210. [DOI] [PubMed] [Google Scholar]
  6. Chatterji S., Ustun B., Bickenbach J. E. What is disability after all? Disabil Rehabil. 1999 Aug;21(8):396–398. doi: 10.1080/096382899297549. [DOI] [PubMed] [Google Scholar]
  7. Creemers M. C., Van 't Hof M. A., Franssen M. J., Van de Putte L. B., Gribnau F. W., Van Riel P. L. A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study. Br J Rheumatol. 1994 Sep;33(9):842–846. doi: 10.1093/rheumatology/33.9.842. [DOI] [PubMed] [Google Scholar]
  8. Daltroy L. H., Larson M. G., Roberts N. W., Liang M. H. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol. 1990 Jul;17(7):946–950. [PubMed] [Google Scholar]
  9. Dougados M., Gueguen A., Nakache J. P., Nguyen M., Mery C., Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol. 1988 Feb;15(2):302–307. [PubMed] [Google Scholar]
  10. Garrett S., Jenkinson T., Kennedy L. G., Whitelock H., Gaisford P., Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994 Dec;21(12):2286–2291. [PubMed] [Google Scholar]
  11. Gray D. B., Hendershot G. E. The ICIDH-2: developments for a new era of outcomes research. Arch Phys Med Rehabil. 2000 Dec;81(12 Suppl 2):S10–S14. doi: 10.1053/apmr.2000.20616. [DOI] [PubMed] [Google Scholar]
  12. Kazis L. E., Anderson J. J., Meenan R. F. Effect sizes for interpreting changes in health status. Med Care. 1989 Mar;27(3 Suppl):S178–S189. doi: 10.1097/00005650-198903001-00015. [DOI] [PubMed] [Google Scholar]
  13. Liang M. H., Fossel A. H., Larson M. G. Comparisons of five health status instruments for orthopedic evaluation. Med Care. 1990 Jul;28(7):632–642. doi: 10.1097/00005650-199007000-00008. [DOI] [PubMed] [Google Scholar]
  14. Ruof J., Sangha O., Stucki G. Comparative responsiveness of 3 functional indices in ankylosing spondylitis. J Rheumatol. 1999 Sep;26(9):1959–1963. [PubMed] [Google Scholar]
  15. Spoorenberg A., van der Heijde D., de Klerk E., Dougados M., de Vlam K., Mielants H., van der Tempel H., van der Linden S. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. J Rheumatol. 1999 Apr;26(4):961–965. [PubMed] [Google Scholar]
  16. Ward M. M. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res. 1999 Aug;12(4):247–255. [PubMed] [Google Scholar]
  17. Ward M. M., Kuzis S. Validity and sensitivity to change of spondylitis-specific measures of functional disability. J Rheumatol. 1999 Jan;26(1):121–127. [PubMed] [Google Scholar]
  18. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]
  19. van Tubergen A., Landewé R., van der Heijde D., Hidding A., Wolter N., Asscher M., Falkenbach A., Genth E., Thè H. G., van der Linden S. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2001 Oct;45(5):430–438. doi: 10.1002/1529-0131(200110)45:5<430::aid-art362>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES